A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Ling Guan, Junli Wei, Wenzeng Yang, Hong Luo et al.
Citations
1 citations
Journal
BMC Medicine
Topics
Prostate Cancer Treatment and Research
Field-Weighted Citation Impact (FWCI)
1.52
article
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Ling Guan, Junli Wei, Wenzeng Yang, Hong Luo, Bin Wu, Huixin Ge, Tao Dai, H. Chen, Xuepei Zhang, Xiaolin Lü, Dexin Yu, Xin Yao, Chaohong He, Jitao Wu, Yongdong Zhang, Jiexin Luo, G. Chen, Quanren Wang, Linzhong Cheng, Bin Zheng, Houbao Huang, Tiwu Fan, Xiaofeng Chen, Xiaoping Zhang, Jian Li, Xue Chen, Qilin Wang, Huan Wang, Dingwei Ye, Benkang Shi, Bin Fu, Zhenqiang Xu, Yong Wang
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 23(1)
Institutions
Hebei Medical University (CN), Central South University (CN), Nanchang University (CN), Guiyang Medical University (CN), Harbin Medical University (CN), Chongqing University (CN), Anhui Medical University (CN), Changzhi Medical College (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Yuhuangding Hospital (CN), Zhengzhou University (CN), Fudan University Shanghai Cancer Center (CN), People 's Hospital of Jilin Province (CN), Zhangzhou Municipal Hospital of Fujian Province (CN), Third Affiliated Hospital of Harbin Medical University (CN), Affiliated Hospital of Guizhou Medical University (CN), Xingtai People's Hospital (CN), Hunan Cancer Hospital (CN), Dongguan People’s Hospital (CN), Wuhan Union Hospital (CN), Sanya Central Hospital (CN), Affiliated Hospital of Hebei University (CN), Jiangsu Hengrui Medicine (China) (CN), Second Affiliated Hospital of Anhui Medical University (CN), First Affiliated Hospital of Bengbu Medical College (CN), Chenzhou First People's Hospital (CN), Chongqing Cancer Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Qilu Hospital of Shandong University (CN), First Affiliated Hospital of Nanchang University (CN), First Affiliated Hospital of Wannan Medical College (CN), Southern Medical University (CN), China Medical University (CN)